Cited by 399Cancer Risks and FactorsEstrogen and related hormone effectsMenopause: Health Impacts and Treatments

Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies

Open access
†·2013·The Lancet Oncology

Abstract

BACKGROUND: Associations between circulating concentrations of oestrogens, progesterone, and androgens with breast cancer and related risk factors in premenopausal women are not well understood. We aimed to characterise these associations with a pooled analysis of data from seven studies. METHODS: Individual participant data for prediagnostic sex hormone and sex hormone-binding globulin (SHBG) concentrations were contributed from seven prospective studies. We restricted analyses to women who were premenopausal and younger than 50 years at blood collection, and to women with breast cancer diagnosed before age 50 years. We estimated odds ratios (ORs) with 95% CIs for breast cancer associated with hormone concentrations by conditional logistic regression in cases and controls matched for age, date of blood collection, and day of cycle, with stratification by study and further adjustment for cycle phase. We examined associations of hormones with risk factors for breast cancer in control women by comparing geometric mean hormone concentrations in categories of these risk factors, adjusted for study, age, phase of menstrual cycle, and body-mass index (BMI). All statistical tests were two-sided. FINDINGS: We included data for up to 767 women with breast cancer and 1699 controls in the risk analyses. Breast cancer risk was associated with a doubling in concentrations of oestradiol (OR 1·19, 95% CI 1·06-1·35), calculated free oestradiol (1·17, 1·03-1·33), oestrone (1·27, 1·05-1·54), androstenedione (1·30, 1·10-1·55), dehydroepiandrosterone sulphate (1·17, 1·04-1·32), testosterone (1·18, 1·03-1·35), and calculated free testosterone (1·08, 0·97-1·21). Breast cancer risk was not associated with luteal phase progesterone (doubling in concentration OR 1·00, 95% CI 0·92-1·09), and adjustment for other factors had little effect on any of these ORs. Cross-sectional analyses in control women showed several associations of sex hormones with breast cancer risk factors. INTERPRETATION: Circulating oestrogens and androgens are positively associated with the risk for breast cancer in premenopausal women.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s1470-2045(13)70301-2

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Circulating estrogens are associated with increased breast cancer risk in women, and this cancer is related to alcohol intake.

    “Because circulating estrogens are associated to an increased breast cancer risk in women, [123][124][125] and this cancer is related to alcohol intake, 126,127”
  • Alcohol may affect serum levels of hormones and related signalling pathways, leading to an increased risk of breast cancer, and possibly of prostate, ovarian and endometrial cancers.

    “Secondly, alcohol may affect serum levels of hormones and related signalling pathways, leading to an increased risk of breast cancer, and possibly of prostate, ovarian and endometrial cancers 153, 154, 155.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
†
Corresponding author
†
Venue
The Lancet Oncology
Publisher
Elsevier BV
Published
2013-09
Volume
14
Issue
10
Pages
1009-1019
ISSN
1470-2045 (ISSN-L)
OpenAlex
W157836986
Cited by
399
References
42
Citations by year
2026: 27 · 2025: 39 · 2024: 34 · 2023: 32 · 2022: 38 · 2021: 38 · 2020: 38 · 2019: 22 · 2018: 24 · 2017: 22 · 2016: 23 · 2015: 33 · 2014: 27 · 2013: 2
FWCI
15.18
Type
journal article
Language
en
Open access
Locations
  • The Lancet Oncology (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
Funders
  • National Institute for Health and Care Research (NF-SI-0512-10122)
  • National Cancer Institute (R01CA050385, R01CA067262)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Risks and Factors
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Estrogen and related hormone effects
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
Keywords
premenopausal women, sex hormones, estradiol, estrone, androgens, testosterone, dehydroepiandrosterone sulfate, androstenedione, progesterone, sex hormone-binding globulin, menstrual cycle phases, breast cancer risk factors, body mass index
MeSH terms
Adult, Breast Neoplasms, Cooperative Behavior, Female, Humans, Prospective Studies, Sex Hormone-Binding Globulin, Gonadal Steroid Hormones, Body Mass Index, Premenopause, Dehydroepiandrosterone Sulfate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review